Company intelligence / Profile preview
Maxwellia
Alderley Edge, England, United Kingdommaxwellia.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Maxwellia is a consumer healthcare company specializing in 'switching' prescription medicines to over-the-counter (OTC) status, focusing on women's health. Its current OTC brands include Ultravana (naproxen) for period pain, Evana (tranexamic acid) for heavy menstrual bleeding, Lovima (progestogen-only pill) for daily contraception, and LoviOne (ulipristal acetate) for emergency contraception. These products are already commercially available in the UK.
- Therapeutic areas
- Women's Health
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Maxwellia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Maxwellia.